Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke
Clinical trial NCT05745311 · UNKNOWN
Trial details
- NCT number
- NCT05745311
- Sponsor
- Kunming Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2024-05-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.